Coeptis Therapeutics (COEP) and Bull Horn Holdings Announce SPAC Merger
b'Coeptis Therapeutics CEO David Mehalick joins The Watchlist to discuss the company, which focuses on developing cell therapy platforms for cancer patients. The company recently announced merging with SPAC Bull Horn Holdings, which is anticipated to close in the 3Q of 2022.'